Antibodies News and Research

RSS

Trop-2 new target for anti-tumour therapy in cancer

Italian scientists announced (Monday September 24) that they have found a new and promising target for anti-tumour therapy in cancer.

25 Sep 2007

Adnexus Therapeutics to become a subsidiary of Bristol-Myers Squibb

Bristol-Myers Squibb and Adnexus Therapeutics have announced the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Adnexus Therapeutics, developer of a new therapeutic class of biologics called Adnectins.

25 Sep 2007

MIT model could improve some drugs' effectiveness

MIT researchers have developed a computer modeling approach that could improve a class of drugs based on antibodies, molecules key to the immune system.

24 Sep 2007

When biological molecules kiss, a new kind of biosensor can tell

A new and deceptively simple technique has been developed by chemists at Vanderbilt University that can measure the interactions between free-floating, unlabeled biological molecules including proteins, sugars, antibodies, DNA and RNA.

21 Sep 2007

10% of women infected with human papillomavirus by age 16

A new study by the Health protection Agency estimates at least 10% of young women in England have been infected with one or more strains of the human papillomavirus (HPV) by the age of 16. The study will be discussed on the last day of the Health Protection Agency annual conference in Warwick.

20 Sep 2007

Childhood vaccination for the rubella virus may protect adult eyes

Childhood vaccination for the rubella virus may have also almost entirely eliminated an inflammatory eye disease from the U.S.-born population, according to a study by researchers at the University of Illinois at Chicago.

20 Sep 2007

Possible hepatitis C vaccine

The British Midlands Development Corporation has announced that the University of Nottingham in the British Midlands has released a statement promoting the development of a possible Hepatitis C Vaccine.

18 Sep 2007

Re-engineered human T cells effectively target and kill cancerous B cells

Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia (ALL), according to researchers at Memorial Sloan-Kettering Cancer Center (MSKCC).

18 Sep 2007

Oxford Genome Sciences partners with Medarex

Oxford Genome Sciences (UK) Ltd (OGeS) has announced a second partnering agreement with Medarex, Inc.

18 Sep 2007

Gene profiling can single out the worst cases of multiple myeloma and guide therapy

Multiple myeloma patients vary widely in how they respond to treatment, but now researchers at the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences have identified a small subset of genes whose activity could predict high-risk cases and potentially guide therapy in the future.

18 Sep 2007

New technology for cancer screening listens for the signs of cancer

Cancer-sensing devices built as cheaply and efficiently as wristwatches - using many of the same operating principles - could change the way clinicians detect, treat and monitor cancer in patients.

18 Sep 2007

Secrets of protein folding revealed

A team led by biophysicist Jeremy Smith of the University of Tennessee and Oak Ridge National Laboratory (ORNL) has taken a significant step toward unraveling the mystery of how proteins fold into unique, three-dimensional shapes.

18 Sep 2007

FDA licenses 15 new blood typing tests

The U.S. Food and Drug Administration today licensed 15 new blood typing tests that were previously unavailable in the United States.

17 Sep 2007

New understanding of immune infertility

Most of us have never heard of immune infertility, yet it prevents many prospective parents from conceiving. Immune infertility is one of 80 autoimmune disorders, a group that includes better-known diseases like Multiple Sclerosis and Type 1 Diabetes.

13 Sep 2007

Sugar key to malaria parasite invasion

Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified a sugar in mosquitoes that allows the malaria-causing parasite, Plasmodium falciparum, to attach itself to the mosquito's gut.

11 Sep 2007

First-degree relatives of patients with primary biliary cirrhosis more likely to have biomarkers of the disease

Armed with this new information, physicians could screen and assess first-degree relatives of PBC patients with a simple blood test, enabling them to diagnose and treat more patients before the disease causes irreversible liver damage. These findings were published in this month's issue of Hepatology.

11 Sep 2007

Scientists shed new light on how antibodies fight HIV

By furthering scientists' understanding of the molecular mechanisms that separate the minority of successful HIV antibodies from the majority of ineffective antibodies, the work may have implications for future attempts to design an HIV vaccine.

10 Sep 2007

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Celgene International Sarl has announced that it's oral cancer drug, Revlimid (lenalidomide) has been granted approval by the Swiss Agency for Therapeutic Products (Swissmedic) for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy.

5 Sep 2007

Discovery of monoclonal antibodies which may make a successful Hepatitis C vaccine a reality

Hepatitis C Virus (HCV) infects up to 500,000 people in the UK alone, many of the infections going undiagnosed.

4 Sep 2007

Mice stressed in simulated weightlessness show organ atrophy

A ground-based, experimental model used to simulate astronaut weightlessness in space has provided Rutgers scientists an opportunity to study the effects of stress on immune organs.

4 Sep 2007